In a new study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs ...
The FDA issued its first stamp of approval for a cell or gene therapy back in 2017 to Novartis' Kymriah. | The gene therapy ...
FDA supports CaaMTech's CT-4201 psilocin program for depression, advancing psychedelic therapy and clearing key regulatory ...
A primary benefit of the FDA Fast Track designation is how it accelerates the drug approval process. Early and continuous ...
The FDA designated 166 products under its breakthrough devices program in its most recent financial year, reversing the ...
The Food and Drug Administration (FDA) has expanded the approval of Nerivio ® (Theranica) to include the acute and/or preventive treatment of migraine with or without aura in patients 8 years of age ...
18hon MSN
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
The FDA has followed in the footsteps of its European counterparts and granted accelerated approval to PTC Therapeutics’ gene ...
It may be tough to single out any particular ones as the worst of the bunch, but allow me to suggest two contenders: tech ...
It may be tough to single out any particular ones as the worst of the bunch, but allow me to suggest two contenders: tech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback